Apolipoprotein A5: an emerging paradigm for genetic associations and interactions in lipoprotein and cardiovascular research

about

Apolipoprotein A5: an emerging paradigm for genetic associations and interactions in lipoprotein and cardiovascular research

Item

http://www.wikidata.org/entity/Q57336937

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у квітні 2007

@uk

name

Apolipoprotein A5: an emerging ...... in and cardiovascular research

@en

Apolipoprotein A5: an emerging ...... in and cardiovascular research

@nl

type

Item

label

Apolipoprotein A5: an emerging ...... in and cardiovascular research

@en

Apolipoprotein A5: an emerging ...... in and cardiovascular research

@nl

prefLabel

Apolipoprotein A5: an emerging ...... in and cardiovascular research

@en

Apolipoprotein A5: an emerging ...... in and cardiovascular research

@nl

P1476

Apolipoprotein A5: an emerging ...... in and cardiovascular research

@en

P2860

An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing

APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study

Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides

A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia

The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels

Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study

Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review.

Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.

The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk.

P304

115-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/17460875.2.2.115

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

José M. Ordovas

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

lipoprotein